Form 4 holding
Principal Accounting Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 59,465
- Estimated value
- $645,195
- Report date
- 03 Sep 2026
- Price
- $10.85
- Ownership
- Direct
Robert Charles Breedlove - Principal Accounting Officer at Phathom Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Principal Accounting Officer
- Issuer ticker
- PHAT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert Charles Breedlove since 11 Nov 2025
Reported holdings for Robert Charles Breedlove in Phathom Pharmaceuticals, Inc.
Form 4 holding
Principal Accounting Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 8,192
- Estimated value
- $88,880
- Report date
- 03 Sep 2026
- Price
- $10.85
- Ownership
- By 401(k)
Form 4 holding
Principal Accounting Officer
Phathom Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 33,000
- Estimated value
- Report date
- 19 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert Charles Breedlove in Phathom Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.